IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Tumor

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

0.08

h-Index

2024-2025

 9

Rank

2024-2025

 29506

SJR

2024-2025

 0.103

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Tumor
Abbreviation Tumor
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q4); Epidemiology (Q4); Oncology (Q4)
h-index 9
Overall Rank/Ranking 29506
SCImago Journal Rank (SJR) 0.103
Impact Score 0.08
Publisher Shanghai Jiaotong University
Country China
ISSN 10007431
Best Quartile Q4
Coverage History 2007-2024




About Tumor


Tumor is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Epidemiology (Q4); Oncology (Q4). It is published by Shanghai Jiaotong University. The overall rank of Tumor is 29506. According to SCImago Journal Rank (SJR), this journal is ranked 0.103. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 9. The best quartile for this journal is Q4.

The ISSN of Tumor journal is 10007431. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Tumor is cited by a total of 22 articles during the last 3 years (Preceding 2024).


Tumor Impact IF 2024-2025


The Impact IF 2024 of Tumor is 0.08, which is computed in 2025 as per its definition. Tumor IF is increased by a factor of 0 and approximate percentage change is 0% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Tumor Impact IF 2025 Prediction


Impact IF 2024 of Tumor is 0.08. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Tumor. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 0.08
2023 0.08
2022 0.17
2021 0.10
2020 0.13
2019 0.08
2018 0.02
2017 0.04
2016 0.07
2015 0.04
2014 0.12

Tumor h-index


  Table Setting

Tumor has an h-index of 9. It means 9 articles of this journal have more than 9 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Tumor ISSN


The ISSN of Tumor is 10007431. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Tumor Rank and SCImago Journal Rank (SJR)


The overall rank of Tumor is 29506. According to SCImago Journal Rank (SJR), this journal is ranked 0.103. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Tumor by Year


Year SJR
2025/2026 Coming Soon
2024 0.103
2023 0.104
2022 0.104
2021 0.103
2020 0.114
2019 0.107
2018 0.106
2017 0.108
2016 0.111
2015 0.115
2014 0.124

Ranking of Tumor by Year


Year Ranking
2025/2026 Coming Soon
2024 29506
2023 27451
2022 26169
2021 25386
2020 27943
2019 26947
2018 28207
2017 27936
2016 27152
2015 25691
2014 23701

Tumor Publisher


Table Setting

Tumor is published by Shanghai Jiaotong University. It's publishing house is located in China. Coverage history of this journal is as following: 2007-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Tumor is Tumor. This abbreviation ('Tumor') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Tumor


If your research field is/are related to Cancer Research (Q4); Epidemiology (Q4); Oncology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Tumor?

Tumor latest impact IF is 0.08. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.17 (2022) and 0.02 (2018), respectively, in the last 11 years. Moreover, its average IS is 0.08 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Tumor?

The Tumor has an SJR (SCImago Journal Rank) of 0.103, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.124 in 2014 and the lowest being 0.103 in 2024. Furthermore, the average SJR of the Tumor over the previous 11-year period stands at 0.08.


What's the latest h-index of the Tumor?

The latest h-index of the Tumor is 9.


Who's the publisher of the Tumor?

The Tumor is published by the Shanghai Jiaotong University, with its country of publication being the China.


What's the current ranking of the Tumor?

The Tumor is currently ranked 29506 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 23701 in 2014 and its lowest position of 29506 in 2024.


What's the abbreviation or short name for the Tumor?

The standard ISO4 abbreviation for the Tumor is Tumor.


Is the "Tumor" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Tumor is classified as a journal that the Shanghai Jiaotong University publishes.


What's the scope or major areas of the Tumor?

The Tumor encompasses the following areas:

  • Cancer Research
  • Epidemiology
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Tumor?

The Tumor is assigned the following International Standard Serial Numbers (ISSN): 10007431.


What's the best quartile of the Tumor?

The best quartile for the Tumor is Q4 (2024).


What's the coverage history of the Tumor?

The Tumor coverage history can be summarized as follows: 2007-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Child and Family Social Work journal 8793 Wiley-Blackwell Publishing Ltd 78 2.42
British Journal of Special Education journal 14055 Wiley-Blackwell Publishing Ltd 45 1.43
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29
SPE International Formation Damage Control Symposium Proceedings conference and proceedings 21934 16 0.00
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria journal 25905 National Association of Resident Doctors of Nigeria 25 0.00
East African journal of public health journal 19634 East African Public Health Association 23 0.00
English Literary Renaissance journal 29995 University of Chicago Press 23 0.24
PLoS ONE journal 6756 Public Library of Science 467 2.82
Society and Economy journal 18195 Akademiai Kiado 19 1.57
Acta Bioethica journal 20953 Universidad de Chile - Centro Interdisciplinario de Estudios en Bioetica 12 0.43

Check complete list




Year wise Impact Score (IS) of Tumor

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 0.08
2023 0.08
2022 0.17
2021 0.10
2020 0.13
2019 0.08
2018 0.02
2017 0.04
2016 0.07
2015 0.04
2014 0.12



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Epidemiology

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries / CDC
Centers for Disease Control and Prevention (CDC) | United States

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Clinical Microbiology Reviews
American Society for Microbiology | United States

Lancet HIV,The
Elsevier Ltd | United Kingdom

Journal of the American Society of Nephrology : JASN
Wolters Kluwer Health | United States

Alzheimer's and Dementia
John Wiley and Sons Inc | United States

European Journal of Epidemiology
Springer Netherlands | Netherlands

Journal of Clinical Epidemiology
Elsevier Inc. | United States

International Journal of Epidemiology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Annals of Oncology
Elsevier Ltd | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

See All